Terms: = Prostate cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Prognosis
3 results:
1. Contrast-Enhanced Ultrasound-Magnetic Resonance Imaging Radiomics Based Model for Predicting the Biochemical Recurrence of prostate cancer: A Feasibility Study.
Wang Y; Feng G; Wang J; An P; Duan P; Hu Y; Ye Y; Li Y; Qin P; Song P
Comput Math Methods Med; 2022; 2022():8090529. PubMed ID: 35529273
[TBL] [Abstract] [Full Text] [Related]
2. Database Mining of Genes of Prognostic Value for the prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract] [Full Text] [Related]
